Dellora Investments Master Fund LP 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:09 am Sale |
2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Dellora Investments Master Fund LP | 0 0.000% |
-43,250 (Position Closed) |
Filing |
| 2023-02-13 4:16 pm Unchanged |
2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Dellora Investments Master Fund LP | 43,250 5.200% |
0 (Unchanged) |
Filing |
| 2022-08-22 1:17 pm Purchase |
2022-08-11 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Dellora Investments Master Fund LP | 43,250 5.200% |
43,250 (New Position) |
Filing |